Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms

Journal of Physiology

Volumn 592, Issue 7, 2014, Pages 1705-1720

  How, Jackie M Y ^a   Wardak, Suhail A ^a   Ameer, Shaik I ^a   Davey, Rachel A ^a   Sartor, Daniela M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; MESSENGER RNA; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE ACTION; HYPERTENSION; LIPID DIET; LOW FAT DIET; MALE; MEDULLA OBLONGATA; NODOSE GANGLION; NONHUMAN; OBESITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; SYMPATHETIC BLOCKING; VAGUS NERVE; VASODILATATION; VASOMOTOR REFLEX; ADRENERGIC SYSTEM; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ARTERIAL PRESSURE; BAROREFLEX; CHOLECYSTOKININ; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; MEDULLA OBLONGATA; NEURAL INHIBITION; NODOSE GANGLION; OBESITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 84897417152     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.269670     Document Type: Article

References (61)

1. Blevins JE & Baskin DG (2010). Hypothalamic-brainstem circuits controlling eating. Forum Nutr 63, 133-140.
2. Burman KJ, Sartor DM, Verberne AJ & Llewellyn-Smith IJ (2004). Cocaine- and amphetamine-regulated transcript in catecholamine and noncatecholamine presympathetic vasomotor neurons of rat rostral ventrolateral medulla. J Comp Neurol 476, 19-31.
3. Cai D & Liu T (2012). Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging 4, 98-115.
4. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL, et al. (2008). Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diab Care 31, 2211-2221.
5. Cates MJ, Dickinson CJ, Hart EC & Paton JF (2012). Neurogenic hypertension and elevated vertebrobasilar arterial resistance: is there a causative link? Curr Hypertens Rep 14, 261-269.
6. Covasa M, Grahn J & Ritter RC (2000a). High fat maintenance diet attenuates hindbrain neuronal response to CCK. Regul Peptides 86, 83-88.
7. Covasa M, Grahn J & Ritter RC (2000b). Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet. Auton Neurosci 84, 8-18.
8. Daly DM, Park SJ, Valinsky WC & Beyak MJ (2011). Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol 589, 2857-2870.
9. Davey RA, Hahn CN, May BK & Morris HA (2000). Osteoblast gene expression in rat long bones: effects of ovariectomy and dihydrotestosterone on mRNA levels. Calcif Tiss Int 67, 75-79.
10. Davey RA, Turner AG, McManus JF, Chiu WS, Tjahyono F, Moore AJ, et al. (2008). Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res 23, 1182-1193.
11. de Lartigue G, de La Serre CB & Raybould HE (2011). Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. Physiol Behav 105, 100-105.
12. de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC & Raybould HE (2010). Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-G448.
13. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
14. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G & Lambert E (2006). Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796.
15. Fardin NM, Oyama LM & Campos RR (2012). Changes in baroreflex control of renal sympathetic nerve activity in high-fat-fed rats as a predictor of hypertension. Obesity 20, 1591-1597.
16. Fink GD (2010). Does our fat tell our brain what to do? A sympathetic' appraisal. J Physiol 588, 1389-1390.
17. Gordon FJ & Mark AL (1984). Mechanism of impaired baroreflex control in prehypertensive Dahl salt-sensitive rats. Circ Res 54, 378-387.
18. Grassi G (2004). Leptin, sympathetic nervous system, and baroreflex function. Curr Hypertens Rep 6, 236-240.
19. Grassi G, Seravalle G & Dell'oro R (2010a). Sympathetic activation in obesity: a noninnocent bystander. Hypertension 56, 338-340.
20. Grassi G, Seravalle G & Quarti-Trevano F (2010b). The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581-586.
21. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
22. Hall JE, da Silva AA, Brandon E, Stec DE, Ying Z & Jones DW (2007). Pathophysiology of obesity-induced hypertension and target organ damage. In Comprehensive Hypertension, eds Lipp, GYP & Hall JE, pp. 447-468. Elsevier, New York.
23. How JM, Fam BC, Verberne AJ & Sartor DM (2011). High fat diet is associated with blunted splanchnic sympathoinhibitory responses to gastric leptin and cholecystokinin: implications for circulatory control. Am J Physiol Heart Circ Physiol 300, H961-H967.
24. How JM, Pumpa TJ & Sartor DM (2013a). The circulatory and renal sympathoinhibitory effects of gastric leptin are altered by a high fat diet and obesity. Autonom Neurosci 177, 95-100.
25. How JM, Pumpa TJ & Sartor DM (2013b). Renal sympathoinhibitory and regional vasodilator responses to cholecystokinin are altered in obesity-related hypertension. Exp Physiol 98, 655-664.
26. Huber DA & Schreihofer AM (2011). Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats. Am J Physiol Heart Circ Physiol 301, H230-H240.
27. Huber DA & Schreihofer AM (2010). Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms. J Physiol 588, 1515-1525.
28. Jordan J, Heusser K, Brinkmann J & Tank J (2012). Electrical carotid sinus stimulation in treatment resistant arterial hypertension. Autonom Neurosci 172, 31-36.
29. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, et al. (2010a). Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 56, 351-358.
30. Lambert GW, Straznicky NE, Lambert EA, Dixon JB & Schlaich MP (2010b). Sympathetic nervous activation in obesity and the metabolic syndrome - causes, consequences and therapeutic implications. Pharmacol Ther 126, 159-172.
31. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224-2260.
32. Llewellyn-Smith IJ & Verberne AJM (2011). Central Regulation of Autonomic Functions, 2nd edn. Oxford University Press, New York.
33. Lumeng CN & Saltiel AR (2011). Inflammatory links between obesity and metabolic disease. J Clinical Invest 121, 2111-2117.
34. McCully BH, Brooks VL & Andresen MC (2012). Diet-induced obesity severely impairs myelinated aortic baroreceptor reflex responses. Am J Physiol Heart Circ Physiol 302, H2083-H2091.
35. Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC & D'Agostino R (2005). Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch Intern Med 165, 1298-1303.
36. Myers EA & Rinaman L (2002). Viscerosensory activation of noradrenergic inputs to the amygdala in rats. Physiol Behav 77, 723-729.
37. Nefti W, Chaumontet C, Fromentin G, Tome D & Darcel N (2009). A high-fat diet attenuates the central response to within-meal satiation signals and modifies the receptor expression of vagal afferents in mice. Am J Physiol Regul Integr Comp Physiol 296, R1681-R1686.
38. Osborn JW, Fink GD & Kuroki MT (2011). Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep 13, 221-228.
39. Paulino G, Barbier de la Serre C, Knotts TA, Oort PJ, Newman JW, Adams SH, et al. (2009). Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. Am J Physiol Endocrinol Metab 296, E898-E903.
40. Paxinos G, Carrive P, Wang H & Wong P-Y (1999). Chemoarchitectonic Atlas of the Rat Brainstem. Spi edn. Academic Press, London.
41. Plump A (2010). Accelerating the pulse of cardiovascular R&D. Nat Rev Drug Discov 9, 823-824.
42. Prentice AM & Jebb SA (2003). Fast foods, energy density and obesity: a possible mechanistic link. Obes Rev 4, 187-194.
43. Sartor DM (2013). Sympathoinhibitory signals from the gut and obesity-related hypertension. Clin Auton Res 23, 33-39.
44. Sartor DM, Shulkes A & Verberne AJ (2006a). An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats. Am J Physiol Regul Integr Comp Physiol 290, R625-R633.
45. Sartor DM & Verberne AJ (2006b). The sympathoinhibitory effects of systemic cholecystokinin are dependent on neurons in the caudal ventrolateral medulla in the rat. Am J Physiol Regul Integr Comp Physiol 291, R1390-R1398.
46. Sartor DM & Verberne AJ (2007). The role of NMDA and non-NMDA receptors in the NTS in mediating three distinct sympathoinhibitory reflexes. Naunyn Schmiedebergs Arch Pharmacol 376, 241-252.
47. Sartor DM & Verberne AJ (2008). Abdominal vagal signalling: a novel role for cholecystokinin in circulatory control? Br Res Rev 59, 140-154.
48. Sartor DM & Verberne AJ (2010). Gastric leptin: a novel role in cardiovascular regulation. Am J Physiol Heart Circ Physiol 298, H406-H414.
49. Sartor DM & Verberne AJM (2002). Cholecystokinin selectively affects presympathetic vasomotor neurons and sympathetic vasomotor outflow. Am J Physiol Regul Integr Comp Physiol 282, R1174-R1184.
50. Sartor DM & Verberne AJM (2003). Phenotypic identification of rat rostroventrolateral medullary presympathetic vasomotor neurons inhibited by exogenous cholecystokinin. J Comp Neurol 465, 467-479.
51. Schreihofer AM & Guyenet PG (1997). Identification of C1 presympathetic neurons in rat rostral ventrolateral medulla by juxtacellular labelling in vivo. J Comp Neurol 387, 524-536.
52. Schreihofer AM, Mandel DA, Mobley SC & Stepp DW (2007). Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. Am J Physiol Heart Circ Physiol 293, H2543-H2549.
53. Stocker SD, Meador R & Adams JM (2007). Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension 49, 640-646.
54. Undem BJ & Weinreich D (2005). Advances in Vagal Afferent Neurobiology. 1st edn. Taylor & Francis, Boca Raton, FL, USA.
55. Verberne AJM & Sartor DM (2004). Cholecystokinin-induced inhibition of presympathetic vasomotor neurons: dependence on sub-diaphragmatic vagal afferents and central NMDA receptors in the rat. Am J Physiol Regul Integr Comp Physiol 287, R809-R816.
56. Viltart O, Sartor DM & Verberne AJ (2006). Chemical stimulation of visceral afferents activates medullary neurones projecting to the central amygdala and periaqueductal grey. Brain Res Bull 71, 51-59.
57. Waki H, Gouraud SS, Maeda M & Paton JF (2010). Evidence of specific inflammatory condition in nucleus tractus solitarii of spontaneously hypertensive rats. Exp Physiol 95, 595-600.
58. Waki H, Gouraud SS, Maeda M, Raizada MK & Paton JF (2011). Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Resp Physiol Neurobiol 178, 422-428.
59. Waki H, Hendy EB, Hindmarch CC, Gouraud S, Toward M, Kasparov S, et al. (2013). Excessive leukotriene B4 in nucleus tractus solitarii is prohypertensive in spontaneously hypertensive rats. Hypertension 61, 194-201.
60. Weston M, Wang H, Stornetta RL, Sevigny CP & Guyenet PG (2003). Fos expression by glutamatergic neurons of the solitary tract nucleus after phenylephrine-induced hypertension in rats. J Comp Neurol 460, 525-541.
61. Zhao D, McCully BH & Brooks VL (2012). Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity. J Pharmacol Exp Ther 343, 206-213.